Physician Assistant · South San Francisco, CA
NPI
1396091542
Since 2012
Specialty
Physician Assistant
Code 363A00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
192 Beacon St
South San Francisco, CA, 94080
Phone (650) 589-6500
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.8M
3,445 prescriptions
Company payments, 2025
$4,211
From 18 companies
Medicare prescription drug claims, 2024
In 2024, the drug Lucas D French prescribed most often to Medicare patients was Atorvastatin Calcium, with 193 prescriptions and refills. In total Lucas D French wrote 3,445 Medicare prescriptions that cost $1.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 193 | 445 | 57 | $1,297 |
| Gabapentin Generic | 93 | 154 | 22 | $1,314 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 80 | 96 | 13 | $372K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 72 | 73 | 21 | $2,145 |
| Valacyclovir Valacyclovir Hcl | 70 | 110 | 17 | $2,119 |
| Descovy Emtricitabine/Tenofov Alafenam | 66 | 68 | Under 11 | $146K |
| Metformin Hcl Er Metformin Hcl | 66 | 106 | 11 | $293 |
| Lisinopril Generic | 62 | 122 | 15 | $188 |
| Xyosted Testosterone Enanthate | 59 | 61 | 14 | $38K |
| Testosterone Generic | 58 | 74 | 22 | $6,415 |
| Metoprolol Succinate Generic | 57 | 115 | 12 | $402 |
| Alprazolam Generic | 55 | 56 | 13 | $163 |
| Losartan Potassium Generic | 54 | 114 | 16 | $265 |
| Acyclovir Generic | 51 | 81 | Under 11 | $597 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 47 | 47 | 19 | $1,879 |
Brand drugs: 879 claims; generic drugs: 2,554 claims; opioid claims: 148.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lucas D French $4,211 ($4,211 in general payments such as food, travel and fees) from 18 companies. The largest payer was ViiV Healthcare Company with $956.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 49 | $956 |
| Gilead Sciences, Inc. GILD | 27 | $792 |
| EMD Serono, Inc. MRK.DE | 21 | $621 |
| Theratechnologies Inc. THTX | 8 | $271 |
| Novo Nordisk Inc NVO | 13 | $267 |
| Abbvie Inc. ABBV | 11 | $254 |
| Antares Pharma, Inc. | 11 | $253 |
| Merck Sharp & Dohme LLC MRK | 7 | $206 |
| Lilly USA, LLC LLY | 5 | $126 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $118 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.